Crinetics Pharmaceuticals, Inc.

CRNX · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$264,545$54,897$32,672$200,695
Short-Term Investments$1,089,524$503,658$301,753$133,012
Receivables$8,470$9,351$2,425$2,029
Inventory$0$0$0$0
Other Curr. Assets$12,849$6,247$8,334$8,984
Total Curr. Assets$1,375,388$574,153$345,184$344,720
Property Plant & Equip (Net)$55,575$57,430$4,986$4,717
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$800$1,770$1,969$1,010
Tax Assets$0$0$0$0
Other NC Assets$2,829$2,000$37$568
Total NC Assets$59,204$61,200$6,992$6,295
Other Assets$0$0$0$0
Total Assets$1,434,592$635,353$352,176$351,015
Liabilities
Payables$5,853$6,548$6,883$3,422
Short-Term Debt$7,152$4,173$1,051$0
Tax Payable$0$0$0$0
Deferred Revenue$2,176$2,056$2,240$0
Other Curr. Liab.$44,503$31,165$17,549$12,573
Total Curr. Liab.$59,684$43,942$27,723$15,995
LT Debt$44,570$47,555$2,024$3,074
Deferred Rev, NC$4,704$4,750$6,101$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$829$0$0$2
Total NC Liab.$50,103$52,305$8,125$3,076
Other Liabilities$0$0$0$0
Cap. Leases$51,722$47,555$2,024$3,074
Total Liabilities$109,787$96,247$35,848$19,071
Equity
Pref Stock$0$0$0$0
Common Stock$2,275,952$1,191,831$759,432$607,581
Retained Earnings-$952,110-$653,702-$439,173-$275,255
AOCI$963$977-$3,931-$382
Other Equity$0$0$0$0
Total Equity$1,324,805$539,106$316,328$331,944
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,434,592$635,353$352,176$351,015
Net Debt-$212,823-$3,169-$29,597-$197,621